Cite

HARVARD Citation

    Wice, M. et al. (n.d.). Predictors of Sustained Treatment With Vedolizumab in Patients With Inflammatory Bowel Disease in a Large Tertiary Medical Center. American journal of gastroenterology. p. . [Online]. 
  
Back to record